Immunotherapy is a rapidly expanding field of oncology aimed at targeting, not the tumor
itself, but the immune system combating the cancerous lesion. Of the many approaches …

Introduction: Although much progress has been made in the last decade (s) toward
development of effective cancer vaccines, there are still important obstacles to therapeutic …

Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments
against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic …

T cell-mediated rejection of tumors requires signals from the T cell receptor and co-
stimulatory molecules to license effector functions of tumor-antigen specific T cells. There is …

Abstract HPV subtypes (16, 18) are associated with the development of cervical cancer, with
oncoproteins E6 and E7 responsible for pathogenesis. The goal of this study was to …

The prognosis of patients with metastatic cervical cancer is poor with a median survival of 8–
13 months. Despite the potency of chemotherapeutic drugs, this treatment is rarely curative …

Infection with human papillomaviruses (HPVs) is very common and associated with benign
and malignant epithelial proliferations of skin and internal squamous mucosae. A subset of …

Dendrimers are structurally well-defined, synthetic polymers with sizes and physicochemical
properties often resembling those of biomacromolecules (eg, proteins). As a result, they are …

Human Papilloma Virus (HPV)-induced (pre-) malignancies offer an excellent case for the
rational design of immunotherapeutic strategies against cancer. Transformed cells express …

Human Papillomavirus (HPV) has been associated with several human cancers, including
cervical cancer, vulvar cancer, vaginal and anal cancer, and a subset of head and neck …